Amalgamated Bank’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$71K Hold
1,626
﹤0.01% 1758
2025
Q1
$45K Buy
1,626
+233
+17% +$6.45K ﹤0.01% 1816
2024
Q4
$56K Hold
1,393
﹤0.01% 1809
2024
Q3
$66K Hold
1,393
﹤0.01% 1776
2024
Q2
$42K Buy
1,393
+68
+5% +$2.05K ﹤0.01% 1896
2024
Q1
$53K Sell
1,325
-4,099
-76% -$164K ﹤0.01% 1853
2023
Q4
$138K Sell
5,424
-394
-7% -$10K ﹤0.01% 1904
2023
Q3
$81K Hold
5,818
﹤0.01% 2072
2023
Q2
$134K Buy
5,818
+1,889
+48% +$43.5K ﹤0.01% 1969
2023
Q1
$116K Sell
3,929
-923
-19% -$27.3K ﹤0.01% 1996
2022
Q4
$121K Hold
4,852
﹤0.01% 2060
2022
Q3
$106K Buy
4,852
+48
+1% +$1.05K ﹤0.01% 2125
2022
Q2
$95K Sell
4,804
-798
-14% -$15.8K ﹤0.01% 2183
2022
Q1
$237K Sell
5,602
-436
-7% -$18.4K ﹤0.01% 1873
2021
Q4
$383K Sell
6,038
-79
-1% -$5.01K ﹤0.01% 1704
2021
Q3
$359K Buy
6,117
+657
+12% +$38.6K ﹤0.01% 1758
2021
Q2
$265K Buy
+5,460
New +$265K ﹤0.01% 1937